The Yield Lab portfolio

The Yield Lab has 2 portfolio companies on record at Recent Funding.

Website: theyieldlab.com.

Type: Venture capital.

Portfolio on Recent Funding: 2.

Deals, last 12 months: 0.

Capital in their rounds: $7.1M.

Latest deal: Plastomics · Nov 16, 2021.

About this page

It is a venture capital firm based in Singapore, SG, founded in 2014. Its most recent investment on record is Plastomics's $7.1M Series A round in November 2021, alongside Lewis & Clark AgriFood, Missouri Technology Corporation, Revolution’s Rise of the Rest Seed Fund and 6 others. By category, its portfolio leans toward Commerce and retail (2) and Health and bio (1).

About The Yield Lab

Firm type: Venture capital.

Headquarters: Singapore, SG.

Founded: 2014.

Stages: Pre-Seed, Seed, Series A.

Sectors: AgTech, FoodTech, Healthtech, Impact & Social Good, Logistics & Supply Chain.

Check size: $48K to $12M.

Leads rounds: Yes.

What The Yield Lab invests in

How The Yield Lab invests

Stage	Deals	Capital in rounds
Series A	1 100%	$7.1M

The Yield Lab portfolio companies

PPlastomics$7.1MSeries A · Nov 2021
BBotanical Solutionbacker

Company	Round with The Yield Lab	Total raised	Latest raise
PPlastomics Health and bio	Nov 16, 2021 Series A · $7.1M	$12.9M	Oct 27, 2025 Series B+
BBotanical Solution Commerce and retail	backer	undisclosed	Aug 26, 2024 Series A

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Commerce and retail).

How this is counted

Firm profile: Fundraising Fox Open Dataset v2026-09, CC BY 4.0. Track-record counts are theirs, not Recent Funding's.

Share is of the 1 round on Recent Funding that name The Yield Lab. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists The Yield Lab, which is a subset of its real portfolio. API: /api/v1/investors/the-yield-lab (get a free API key). More: the most active VC firms and new venture capital funds.